Wells Fargo & Company Codexis, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Codexis, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 31,908 shares of CDXS stock, worth $128,270. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,908

Previous 30,763 3.72%

Holding current value

$128,270

Previous $95,000 3.16%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$2.62 - $3.71 $2,999 - $4,247	1,145 Added 3.72%	31,908 $98,000
Q2 2024 Aug 13, 2024	BUY	$2.65 - $3.92 $14,286 - $21,132	5,391 Added 21.25%	30,763 $95,000
Q1 2024 May 10, 2024	BUY	$2.59 - $4.65 $5,420 - $9,732	2,093 Added 8.99%	25,372 $88,000
Q4 2023 Feb 09, 2024	BUY	$1.54 - $3.37 $7,599 - $16,630	4,935 Added 26.9%	23,279 $71,000
Q3 2023 Nov 13, 2023	SELL	$1.5 - $3.75 $223,792 - $559,481	-149,195 Reduced 89.05%	18,344 $34,000
Q2 2023 Aug 15, 2023	BUY	$2.21 - $4.43 $336,755 - $675,034	152,378 Added 1005.07%	167,539 $469,000
Q1 2023 May 12, 2023	BUY	$3.81 - $6.76 $33,851 - $60,062	8,885 Added 141.57%	15,161 $62,000
Q4 2022 Feb 13, 2023	BUY	$4.26 - $6.84 $16,315 - $26,197	3,830 Added 156.58%	6,276 $29,000
Q3 2022 Nov 14, 2022	SELL	$6.06 - $12.86 $59,139 - $125,500	-9,759 Reduced 79.96%	2,446 $15,000
Q2 2022 Aug 12, 2022	SELL	$8.35 - $21.89 $2.9 Million - $7.6 Million	-347,117 Reduced 96.6%	12,205 $127,000
Q1 2022 May 16, 2022	BUY	$16.97 - $31.93 $91,145 - $171,496	5,371 Added 1.52%	359,322 $7.41 Million
Q4 2021 Feb 14, 2022	SELL	$25.61 - $41.78 $45.7 Million - $74.6 Million	-1,784,526 Reduced 83.45%	353,951 $11.1 Million
Q3 2021 Nov 15, 2021	BUY	$19.65 - $27.99 $2.13 Million - $3.04 Million	108,626 Added 5.35%	2,138,477 $49.7 Million
Q2 2021 Aug 16, 2021	BUY	$17.48 - $25.46 $790,830 - $1.15 Million	45,242 Added 2.28%	2,029,851 $46 Million
Q1 2021 May 13, 2021	SELL	$18.08 - $28.8 $6.05 Million - $9.63 Million	-334,502 Reduced 14.42%	1,984,609 $45.4 Million
Q4 2020 Feb 09, 2021	SELL	$11.7 - $23.41 $1.05 Million - $2.11 Million	-90,037 Reduced 3.74%	2,319,111 $50.6 Million
Q3 2020 Nov 05, 2020	SELL	$11.21 - $13.82 $386,251 - $476,181	-34,456 Reduced 1.41%	2,409,148 $28.3 Million
Q2 2020 Aug 13, 2020	BUY	$9.8 - $12.77 $3.77 Million - $4.91 Million	384,414 Added 18.67%	2,443,604 $27.9 Million
Q1 2020 May 14, 2020	BUY	$8.78 - $18.6 $18.1 Million - $38.3 Million	2,059,190 New	2,059,190 $23 Million

Others Institutions Holding CDXS

# of Institutions

127

Shares Held

48.1M

Call Options Held

33.7K

Put Options Held

20.2K

View Full List

About CODEXIS, INC.

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $263M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

More about CDXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Codexis, Inc. Transaction History